Timothy P Walbert's Insider Trades & SAST Disclosures
Timothy P Walbert's most recent trade in Biomarin Pharmaceutical Inc. - Registered Shares was a trade of 3,130 Common Stock done . Disclosure was reported to the exchange on Feb. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Timothy P Walbert.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biomarin Pharmaceutical In... | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 3,130 | 3,130 (0%) | 0% | 0 | Common Stock | |
| Century Therapeutics Inc | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Sagimet Biosciences Inc - ... | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 9,279 | 9,279 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,779 | 8,779 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 5,703 | 5,703 | - | - | Restricted Stock Units | |
| Sagimet Biosciences Inc - ... | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 73,014 | 73,014 | - | - | Stock Option (Right to Buy) | |
| Century Therapeutics Inc | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 1,417 | 1,417 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 34,000 | 34,000 | - | - | Stock Option (right to buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 219,995 | 713,954 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.24 per share. | 04 Jan 2023 | 97,461 | 616,493 (0%) | 0% | 113.2 | 11,036,484 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 71,290 | 71,290 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 58,055 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 39,944 | 17,448 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 34,928 | 34,929 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 34,835 | 0 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 24,598 | 49,198 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 23,200 | 0 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 20,697 | 20,697 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 9,435 | 0 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 104,498 | 540,324 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 104,498 | 0 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.80 per share. | 30 Dec 2022 | 46,365 | 493,959 (0%) | 0% | 113.8 | 5,276,337 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 15,185 | 56,385 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 7,141 | 14,283 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.80 per share. | 30 Dec 2022 | 6,729 | 49,656 (0%) | 0% | 113.8 | 765,760 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 4,657 | 4,657 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 3,387 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 104,498 | 104,498 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 52,392 | 52,392 | - | - | Performance Restricted Stock Units (PSUs) | |
| Century Therapeutics Inc | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 39,744 | 39,744 | - | - | Stock Option (right to buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2022 | 25,000 | 742,565 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 03 Jun 2022 | 25,000 | 460,826 (0%) | 0% | 22.1 | 553,500 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 92.08 per share. | 03 Jun 2022 | 15,200 | 445,626 (0%) | 0% | 92.1 | 1,399,616 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 92.74 per share. | 03 Jun 2022 | 9,800 | 435,826 (0%) | 0% | 92.7 | 908,852 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 92.04 per share. | 31 May 2022 | 18,500 | 442,049 (0%) | 0% | 92.0 | 1,702,740 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 93.21 per share. | 31 May 2022 | 3,800 | 438,249 (0%) | 0% | 93.2 | 354,198 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 94.46 per share. | 31 May 2022 | 2,700 | 435,549 (0%) | 0% | 94.5 | 255,042 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 25,000 | 767,565 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 20 May 2022 | 25,000 | 460,549 (0%) | 0% | 90 | 2,250,000 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 20 May 2022 | 25,000 | 485,549 (0%) | 0% | 22.1 | 553,500 | Ordinary Shares |
| Aurinia Pharmaceuticals Inc | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 14,612 | 14,612 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Timothy P. Walbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,733 | 8,733 | - | - | Restricted Stock Unit | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 11 May 2022 | 17,600 | 460,549 (0%) | 0% | 90 | 1,584,000 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2022 | 17,600 | 792,565 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 11 May 2022 | 17,600 | 478,149 (0%) | 0% | 22.1 | 389,664 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 7,400 | 810,165 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 06 May 2022 | 7,400 | 467,949 (0%) | 0% | 22.1 | 163,836 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 91.11 per share. | 06 May 2022 | 5,000 | 460,549 (0%) | 0% | 91.1 | 455,550 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 90.33 per share. | 06 May 2022 | 2,400 | 465,549 (0%) | 0% | 90.3 | 216,792 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 95.38 per share. | 02 May 2022 | 13,942 | 471,607 (0%) | 0% | 95.4 | 1,329,788 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 96.62 per share. | 02 May 2022 | 7,608 | 463,999 (0%) | 0% | 96.6 | 735,085 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 97.43 per share. | 02 May 2022 | 3,450 | 460,549 (0%) | 0% | 97.4 | 336,134 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 22 Apr 2022 | 25,000 | 510,549 (0%) | 0% | 22.1 | 553,500 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2022 | 25,000 | 817,565 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 106.10 per share. | 22 Apr 2022 | 16,413 | 494,136 (0%) | 0% | 106.1 | 1,741,419 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 107.02 per share. | 22 Apr 2022 | 5,700 | 488,436 (0%) | 0% | 107.0 | 610,014 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 107.94 per share. | 22 Apr 2022 | 1,800 | 486,636 (0%) | 0% | 107.9 | 194,292 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 109.39 per share. | 22 Apr 2022 | 1,087 | 485,549 (0%) | 0% | 109.4 | 118,907 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2022 | 25,000 | 842,565 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 08 Apr 2022 | 25,000 | 510,549 (0%) | 0% | 22.1 | 553,500 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 112.72 per share. | 08 Apr 2022 | 16,687 | 485,549 (0%) | 0% | 112.7 | 1,880,959 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 111.70 per share. | 08 Apr 2022 | 8,313 | 502,236 (0%) | 0% | 111.7 | 928,562 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 105.52 per share. | 30 Mar 2022 | 35,480 | 485,549 (0%) | 0% | 105.5 | 3,743,850 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 104.61 per share. | 30 Mar 2022 | 14,520 | 521,029 (0%) | 0% | 104.6 | 1,518,937 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 25 Mar 2022 | 25,000 | 560,549 (0%) | 0% | 22.1 | 553,500 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 109.37 per share. | 25 Mar 2022 | 25,000 | 535,549 (0%) | 0% | 109.4 | 2,734,340 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 25,000 | 867,565 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2022 | 25,000 | 892,565 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 11 Mar 2022 | 25,000 | 560,549 (0%) | 0% | 22.1 | 553,500 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 100.77 per share. | 11 Mar 2022 | 18,338 | 542,211 (0%) | 0% | 100.8 | 1,847,920 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 101.38 per share. | 11 Mar 2022 | 6,662 | 535,549 (0%) | 0% | 101.4 | 675,394 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 90.41 per share. | 25 Feb 2022 | 26,892 | 558,657 (0%) | 0% | 90.4 | 2,431,306 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 92.51 per share. | 25 Feb 2022 | 25,000 | 585,549 (0%) | 0% | 92.5 | 2,312,663 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 25 Feb 2022 | 25,000 | 610,549 (0%) | 0% | 22.1 | 553,500 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 25,000 | 917,565 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 91.54 per share. | 25 Feb 2022 | 19,000 | 539,657 (0%) | 0% | 91.5 | 1,739,260 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 92.50 per share. | 25 Feb 2022 | 2,900 | 536,757 (0%) | 0% | 92.5 | 268,250 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 93.57 per share. | 25 Feb 2022 | 1,208 | 535,549 (0%) | 0% | 93.6 | 113,033 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 9,087 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 9,087 | 44,690 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.33 per share. | 01 Feb 2022 | 3,767 | 40,923 (0%) | 0% | 94.3 | 355,341 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 91.94 per share. | 28 Jan 2022 | 74,253 | 596,755 (0%) | 0% | 91.9 | 6,826,821 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 25,000 | 967,565 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 28 Jan 2022 | 25,000 | 710,549 (0%) | 0% | 22.1 | 553,500 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 28 Jan 2022 | 25,000 | 685,549 (0%) | 0% | 90 | 2,250,000 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 90.95 per share. | 28 Jan 2022 | 14,541 | 671,008 (0%) | 0% | 91.0 | 1,322,504 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 92.42 per share. | 28 Jan 2022 | 11,206 | 585,549 (0%) | 0% | 92.4 | 1,035,659 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2022 | 20,336 | 694,558 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2022 | 20,336 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.42 per share. | 21 Jan 2022 | 9,009 | 685,549 (0%) | 0% | 86.4 | 778,558 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 241,750 | 696,232 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.84 per share. | 04 Jan 2022 | 174,906 | 674,222 (0%) | 0% | 101.8 | 17,812,427 | Ordinary Shares |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 152,896 | 849,128 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 73,796 | 73,796 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 58,055 | 58,055 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 58,035 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 46,466 | 23,200 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 44,266 | 44,270 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 34,928 | 69,857 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Timothy P. Walbert | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 21,424 | 21,424 | - | - | Restricted Stock Units (RSU) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges